Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
Prismo Metals Assay Results at Silver King Show Highs of 1.73% copper, 30 ppm molybdenum, 1,362 g/t silver, 4.1% lead, and 1.3 g/t gold
